Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating activities    
Net income $ 62,177 $ 80,194
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation 63,514 56,975
Amortization of intangible and other assets and favorable/unfavorable leases 881 381
Amortization of long-term prepaid rents 639 493
Amortization of debt issue costs 1,590 1,529
Loss on debt amendments 1,484  
Amortization of deferred revenues, deferred lease incentives and other (5,343) (3,822)
Impairment of long-lived assets 591 273
Share based awards compensation expense 3,426 3,241
Loss on sale of assets and other 3,939 834
Deferred lease expenses (483) (347)
Equity in income of affiliates (8,636) (10,060)
Deferred income tax expenses (72) 8,889
Distributions from equity investees [1] 12,323 12,049
Changes in assets and liabilities and other (52,378) (64)
Net cash provided by operating activities 83,652 150,565
Investing activities    
Additions to theatre properties and equipment (80,163) (91,187)
Proceeds from sale of theatre properties and equipment and other 477 3,835
(Investment in) return of investment from joint ventures and other, net 764 (228)
Net cash used for investing activities (78,922) (87,580)
Financing activities    
Dividends paid to stockholders (37,346) (33,760)
Payroll taxes paid as a result of restricted stock withholdings (2,695) (2,694)
Repayments of long-term debt (1,649)  
Payment of debt issue costs (4,962)  
Fees paid related to debt amendments (704)  
Payments on capital leases (6,090) (4,989)
Other   (294)
Net cash used for financing activities (53,446) (41,737)
Effect of exchange rate changes on cash and cash equivalents 215 1,835
Increase (decrease) in cash and cash equivalents (48,501) 23,083
Cash and cash equivalents:    
Beginning of period 522,547 561,235
End of period $ 474,046 $ 584,318
[1] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Notes 7 and 8). These distributions are reported entirely within the U.S. operating segment.